We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
AUM
$315M
AUM Growth
+$23.8M
Cap. Flow
+$26.7M
Cap. Flow %
8.48%
Top 10 Hldgs %
61.35%
Holding
29
New
Increased
13
Reduced
6
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 97.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
26
Lyell Immunopharma
LYEL
$365M
$1.48M 0.47%
5,000
OLK
27
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$970K 0.31%
40,000
PRVA icon
28
Privia Health
PRVA
$2.81B
-96,000
Closed -$4.26M
SEER icon
29
Seer Inc
SEER
$119M
-83,500
Closed -$2.74M

Similar funds

Eagle Health Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Eagle Health Investments held 29 positions worth $315M, up 8.2% from $291M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Eagle Health Investments deployed $26.7M of net new capital in Q3 2021, adding to 13 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 98% a quarter earlier.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $7.93M trimmed.

  • Eagle Health Investments added most to Humana in Q3 2021, an estimated $8.83M increase.
  • Eagle Health Investments's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $7.93M.
  • Eagle Health Investments fully exited Privia Health in Q3 2021, selling an estimated $4.26M.
  • Eagle Health Investments's ten largest holdings make up 61% of its $315M portfolio in Q3 2021.
  • Eagle Health Investments opened 0 new positions and closed 2 in Q3 2021.
  • Eagle Health Investments's portfolio value rose 8.2% quarter-over-quarter to $315M.

Based on Eagle Health Investments's 13F filing for Q3 2021, filed 20 Oct 2021.